Abstract GS3-04: GS3-04 Capivasertib and fulvestrant for patients with aromatase inhibitor-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer…

Overview of attention for article published in Cancer Research, March 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 1 news story.

Several presentations from the 41st Annual Miami Breast Cancer Conference focused on new and evolving data in the space…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.